Trisomy 6 in a CML patient receiving imatinib mesylate therapy-Reference-Cited by-同舟云学术

Trisomy 6 in a CML patient receiving imatinib mesylate therapy

Published:2008-09 Issue:9 Volume:32 Page:1454-1457
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Adriana Zámečníkova,Soad Al Bahar,Pandita Ramesh

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference7 articles.

1. Demonstration of Philadelphia-negative clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate;O’Dwyer;Leukemia,2003

2. Deininger Emergence of clonal cytogenetic abnormalities in Ph− cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority;Bumm;Blood,2003

3. Chronic myelogenous leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression;Marktel;Haematologica,2003

4. Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase;Medina;Cancer,2003

5. Trisomy 6 acquired in lymphoid blast transformation of chronic myelocytic leukemia with t(9;22);Yilmaz;Cancer Genet Cytogenet,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort Study);Turkish Journal of Hematology;2022-12-01